The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors
Related Experiment Video
Updated: Jun 17, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
1Institute of Biomedicine, Department of Pharmacology and Toxicology, Biocenter Oulu, University of Oulu, Oulu, Finland.
Background And Purpose:
The mixed-lineage kinases (MLKs) act upstream of mitogen-activated protein kinases, but their role in cardiac biology and pathology is largely unknown.
Experimental Approach:
We investigated the effect of a MLK1-3 inhibitor CEP-11004 on G protein-coupled receptor agonist-induced stress response in neonatal rat cardiac myocytes in culture.
Key Results:
CEP-11004 administration dose-dependently attenuated phenylephrine and endothelin-1 (ET-1)-induced c-Jun N-terminal kinase activation. MLK inhibition also reduced ET-1- and phenylephrine-induced phosphorylation of p38 mitogen-activated protein kinase. In contrast, phenylephrine-induced extracellular signal-regulated kinase phosphorylation was further up-regulated by CEP-11004. ET-1 increased activator protein-1 binding activity 3.5-fold and GATA-binding protein 4 (GATA-4) binding activity 1.8-fold, both of which were attenuated with CEP-11004 administration by 59% and 63% respectively. Phenylephrine induced activator protein-1 binding activity by 2.6-fold, which was decreased by 81% with CEP-11004 administration. Phenylephrine also induced a 3.7-fold increase in the transcriptional activity of B-type natriuretic peptide (BNP), which was attenuated by 41% with CEP-11004 administration. In agreement, MLK inhibition also reduced hypertrophic agonist-induced secretion of immunoreactive atrial natriuretic peptide and BNP.
Conclusions And Implications:
These results showed that inhibition of the MLK1-3 signalling pathway was sufficient for suppressing the activity of key nuclear effectors (GATA-4 and activator protein-1 transcription factors) in cardiac hypertrophy, and attenuated the agonist-induced atrial natriuretic peptide secretion and activation of BNP gene transcription.
Insights
Mixed-lineage kinase (MLK) inhibition suppresses cardiac hypertrophy by blocking key transcription factors. This study shows MLK1-3 inhibition reduces stress responses and cardiac gene activation in heart cells.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Signal Transduction
Background:
- Mixed-lineage kinases (MLKs) are upstream regulators of mitogen-activated protein kinases (MAPKs).
- The specific role of MLKs in cardiac physiology and pathology remains largely uncharacterized.
Purpose of the Study:
- To investigate the impact of a mixed-lineage kinase 1-3 (MLK1-3) inhibitor, CEP-11004, on G protein-coupled receptor agonist-induced stress responses in neonatal rat cardiac myocytes.
- To elucidate the downstream signaling pathways affected by MLK inhibition in the context of cardiac stress.
Main Methods:
- Primary neonatal rat cardiac myocytes were cultured and treated with G protein-coupled receptor agonists (phenylephrine and endothelin-1).
- The effects of CEP-11004 on c-Jun N-terminal kinase (JNK) and p38 MAPK phosphorylation were assessed.
- Activator protein-1 (AP-1) and GATA-binding protein 4 (GATA-4) binding activities, as well as B-type natriuretic peptide (BNP) gene transcription, were measured.
- Secretion of atrial natriuretic peptide (ANP) and BNP was quantified.
Main Results:
- CEP-11004 dose-dependently attenuated phenylephrine and endothelin-1 (ET-1)-induced c-Jun N-terminal kinase (JNK) activation.
- MLK inhibition reduced ET-1- and phenylephrine-induced p38 MAPK phosphorylation.
- CEP-11004 administration significantly decreased ET-1- and phenylephrine-induced activator protein-1 (AP-1) binding activity.
- MLK inhibition attenuated ET-1-induced GATA-binding protein 4 (GATA-4) binding activity and phenylephrine-induced B-type natriuretic peptide (BNP) gene transcription.
- Agonist-induced secretion of atrial natriuretic peptide (ANP) and BNP was reduced by MLK inhibition.
Conclusions:
- Inhibition of the MLK1-3 signaling pathway effectively suppresses key nuclear effectors, including GATA-4 and AP-1 transcription factors, in models of cardiac hypertrophy.
- MLK1-3 inhibition attenuates agonist-induced atrial natriuretic peptide secretion and B-type natriuretic peptide gene transcription.
- Targeting the MLK1-3 pathway represents a potential therapeutic strategy for mitigating cardiac hypertrophy.
More Related Videos
10:05Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
06:51Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Mitogens and the Cell Cycle